Products for Research Use Only
RegisterLogin

COX-2-IN-57

CAT: 0804-HY-175637Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-175637Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
COX-2-IN-57 is an orally active COX-2 inhibitor with an IC50 value of 0.02 μM. COX-2-IN-57 reduces MyD88 expression and decreases serum levels of COX-2, PGE2, and COX-1 in Cisplatin /radiation-induced neuropathy rat model. COX-2-IN-57 demonstrates superior antinociceptive efficacy in hot plate, cold allodynia, and Randall-Selitto tests, along with hepato-/renal protection. COX-2-IN-57 can be used for the study of inflammation[1].
UNSPSC
12352100
Target
COX; MyD88
Related Pathways
Immunology/Inflammation
Field of Research
Inflammation/Immunology; Neurological Disease
Smiles
O=C(O)CC1=CC=CC=C1N(C2=C(Cl)C=CC=C2Cl)C(CSC(N3C4=CC=CC=C4)=NC5=C(C=C6C(C=CC=C6)=C5)C3=O)=O
Molecular Formula
C34H23Cl2N3O4S
Molecular Weight
640.54
References & Citations
[1]Ghorab MM, et al. Design and synthesis of novel diclofenac-based quinazoline derivatives enhancing cisplatin and radiation impacts via MyD88 and COX-2/PGE2 modulation. Eur J Med Chem. 2025 Nov 15;298:117997.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
COX-1; COX-2

Related Products

CatalogName
HY-101655-01COX-2-IN-2
HY-171992-01COX-2-IN-55
HY-174159COX-2-IN-54
HY-153762-01COX-2-IN-32
HY-145988COX-2-IN-11
HY-146198COX-2-IN-19
HY-U00275COX-2-IN-1
HY-147809COX-2-IN-20
HY-156254COX-2-IN-35
HY-161294COX-2-IN-41

Alternative Products

CatalogName
GTR19273184-01COX-2-IN-57
311865-01Cox-2
GTR19206710-01COX-2-IN-2
BA5932-10COX-2-IN-6
T211247-01COX-2-IN-55
T60457-01COX-2-IN-11
T61714-01COX-2-IN-13
T89933-01COX-2-IN-46
T89018-01COX-2-IN-44
T86083-01COX-2-IN-40

Popular Products